Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs Warfarin)

NCT03596502 · clinicaltrials.gov ↗

COMPLETED

Status

402764

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Ischemic Stroke
Systemic Embolization
Major Bleed
Myocardial Infarction
All-cause Mortality

Interventions

DRUG: Direct oral anticoagulants (DOACs)
DRUG: Warfarin

Sponsor

Canadian Network for Observational Drug Effect Studies, CNODES

Collaborators

[object Object]
[object Object]